[Aprotinin and extracorporeal circulation. What is the benefit? What is the cost?].
Alvarez
J
J
D007611:Aprotinin / Q000009:adverse effects / Q000627:therapeutic use*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D001803:Blood Transfusion; D005112:Extracorporeal Circulation; D006801:Humans; D009846:Oliguria / Q000139:chemically induced*; D013923:Thromboembolism / Q000139:chemically induced*
D007611:Aprotinin